MoneyWorks4Me

Glenmark Life Sciences informs about disclosure

22 Mar 2024 Evaluate
Glenmark Life Sciences has informed that the Company has submitted today March 22, 2024 an application for the reclassification of Glenmark Pharmaceuticals and Glenn Saldanha from ‘promoter and promoter group’ to ‘public shareholders’ to National Stock Exchange of India and BSE for their approval to approve such reclassification.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1843.05
Dr. Reddys Labs. 1218.00
Cipla 1386.80
Lupin 2062.65
Zydus Lifesciences 1222.90
View more..